OBJECTIVES: Upon completion of this activity, the participant should be able to:  (1) 

FACULTY DISCLOSURE: [Speaker Name] has/have no relevant financial relationship(s) with companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

FACULTY DISCLOSURE: [Speaker Name] is/was on (identify relationship and company) the speakers’ bureau for XYZ Device Company.

PLANNER DISCLOSURE: Susan Mathai, MD, is a consultant/researcher for Boehringer Ingelheim, and a researcher for United Therapeutics, Vicore Pharma, Cumberland Pharamceuticals, Atyr Pharam, and was an adviser for Verona, Pharma. Adam Hayek, DO, is a researcher for Foresee Pharmaceuticals, Co., Ltd, Jansen-Sirukumab, Mesoblast Inc., Regeneron, and Kinevant Sciences GmbHand.  Ginger Tsai-Nguyen, MD, planner has no relevant financial relationship(s) with companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships have been mitigated.

PLANNER DISCLOSURE: The planners have no relevant financial relationship(s) with companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

ACCREDITATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

DESIGNATION:  The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For information, please contact Abby Felty at abby.felty@bswhealth.org